pioglitazone and glimepiride

NDC 66993-822 · Prasco Laboratories

Generic namepioglitazone and glimepiride

Dosage formTABLET

RouteORAL

Active ingredient(s)PIOGLITAZONE HYDROCHLORIDE, GLIMEPIRIDE

Strength4; 30 mg/1; mg/1

Pharmacologic classPeroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Sulfonylurea Compounds [CS], Sulfonylurea [EPC], Thiazolidinedione [EPC], Thiazolidinediones [CS]

Marketing categoryNDA AUTHORIZED GENERIC

Packages

66993-822-30 — 30 TABLET in 1 BOTTLE (66993-822-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

64764-451 — pioglitazone, 65862-512 — pioglitazone hydrochloride, 65862-513 — pioglitazone hydrochloride, 65862-514 — pioglitazone hydrochloride, 65862-525 — Pioglitazone Hydrochloride and Metformin Hydrochloride, 65862-526 — Pioglitazone Hydrochloride and Metformin Hydrochloride, 65862-579 — Glimepiride, 65862-580 — Glimepiride, 65862-581 — Glimepiride, 66993-821 — pioglitazone and glimepiride, 67046-1608 — Glimepiride, 68001-584 — Glimepiride, 68001-585 — Glimepiride, 68001-586 — Glimepiride, 68071-2228 — Glimepiride, 68071-2264 — Pioglitazone, 68071-2373 — Pioglitazone, 68071-2385 — Glimepiride, 68071-3639 — Glimepiride, 68071-4964 — Pioglitazone, +171 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.